PR Newswire PharmaOriginal article
GCCL und LabConnect unterzeichnen Absichtserklärung, um die weltweite Zusammenarbeit bei klinischen Studien auszubauen
PartnershipPositive
AI Analysis
Summary
GCCL and LabConnect have signed a memorandum of understanding to expand global collaboration in clinical trials, combining expertise in North America and Asia-Pacific regions to support joint distribution and project execution.
Importance:5/10
Sentiment:
0.30
partnershipcollaborationclinical trialsNorth AmericaAsia-Pacificcentral laboratory
Read the original article
Published by PR Newswire Pharma on October 14, 2026 6:05 AM
